142 said...
If you go back to the posts in 2010 / 2011, one of the big discussions was the German research on the genetic variations of PCa. If I recall, they came up with about 23 variants, which went from deadly with a PSA < 10 to fairly benign with PSAs in the hundreds and more.
University of Michigan, in 2010, published this handy chart
How Aggressive Is That (PC) Tumor showing that most variants of PC were not aggressive. They had identified 24 variants.
Elsewhere, lots of work done elsewhere to show how some relatively small number of PC cases are highly aggressive but put out low values of PSA.
So, the point to the original question,in a small number of cases low PSA is known NOT to correlate to low aggressiveness. In a much larger number of cases, there is a positive correlation; and further, very high PSA values rarely are
not aggressive. But due to the small cases of low PSA not correlated to low aggressiveness (and other reasons, see below), PSA is not used as an measure of aggressiveness. Gleason score is.
PSA doubling time is NOT a valuable measurement for the vast majority of cases pre-treatment. It is very valuable post-treatment, but pre-treatment nobody should use it as a decision tool when PSA is under 20ng/mL because of the extraordinarily common contributions of PSA by other benign factors.
142 said...
about the only reason anyone pulls this up anymore is to start an argument
w-t-f?
Post Edited (NKinney) : 6/4/2018 2:24:14 PM (GMT-6)